Page 17 - Applied Pharmacognosy
P. 17
Commision E monographs:
•“Negative monographs" where there
were risks from active ingredients or
absence of reasonable proof of efficacy.
•Marketing authorizations of a number of herbal
remedies had to be withdrawn from market because
of serious risks to public health.
